Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Epstein

Showing results (1401-1410 of 1,456) with videos related to

Pageof 146
Sort By:
Nature Immunology|November 25, 2014
The methyltransferase Setdb2 mediates virus-induced susceptibility to bacterial superinfectionChristopher Schliehe, Elizabeth K Flynn, Bojan Vilagos, et al.
EFSA Journal. European Food Safety Authority|August 25, 2021
Assessment of genetically modified cotton GHB811 for food and feed uses, under Regulation (EC) No 1829/2003 (application EFSA-GMO-ES-2018-154), Hanspeter Naegeli, Jean Louis Bresson, et al.
EFSA Journal. European Food Safety Authority|November 18, 2024
Assessment of soy leghemoglobin produced from genetically modified <i>Komagataella phaffii</i>, under Regulation (EC) No 1829/2003 (application EFSA-GMO-NL-2019-162), Josep Casacuberta, Francisco Barro, et al.
JAMA Oncology|November 8, 2019
Communication With Older Patients With Cancer Using Geriatric Assessment: A Cluster-Randomized Clinical Trial From the National Cancer Institute Community Oncology Research ProgramSupriya G Mohile, Ronald M Epstein, Arti Hurria, et al.
EFSA Journal. European Food Safety Authority|August 6, 2025
New developments in biotechnology applied to animals: An assessment of the adequacy and sufficiency of current EFSA guidance for animal risk assessment, Josep Casacuberta, Francisco Barro, et al.
EFSA Journal. European Food Safety Authority|February 18, 2021
Evaluation of existing guidelines for their adequacy for the molecular characterisation and environmental risk assessment of genetically modified plants obtained through synthetic biology, Hanspeter Naegeli, Jean-Louis Bresson, et al.
International Journal of Cancer|September 24, 2022
Circulating immune markers and risks of non-Hodgkin lymphoma subtypes: A pooled analysisJongeun Rhee, Brenda M Birmann, Anneclaire J De Roos, et al.
EFSA Journal. European Food Safety Authority|August 31, 2023
Assessment of genetically modified oilseed rape MS11 for food and feed uses, import and processing, under Regulation (EC) No 1829/2003 (application EFSA-GMO-BE-2016-138), Hanspeter Naegeli, Jean-Louis Bresson, et al.
EFSA Journal. European Food Safety Authority|July 7, 2020
Assessment of genetically modified maize Bt11 × MIR162 × MIR604 × 1507 × 5307 × GA21 and subcombinations, for food and feed uses, under Regulation (EC) No 1829/2003 (application EFSA-GMO-DE-2011-103), Hanspeter Naegeli, Jean-Louis Bresson, et al.
EFSA Journal. European Food Safety Authority|July 8, 2025
Assessment of genetically modified soybean DBN9004 (application EFSA-GMO-BE-2019-165), Josep Casacuberta, Francisco Barro, et al.
Pageof 146

Showing results (1401-1410 of 1,456) with videos related to

Sort By:
Pageof 146
Nature Immunology|November 25, 2014
The methyltransferase Setdb2 mediates virus-induced susceptibility to bacterial superinfectionChristopher Schliehe, Elizabeth K Flynn, Bojan Vilagos, et al.
EFSA Journal. European Food Safety Authority|August 25, 2021
Assessment of genetically modified cotton GHB811 for food and feed uses, under Regulation (EC) No 1829/2003 (application EFSA-GMO-ES-2018-154), Hanspeter Naegeli, Jean Louis Bresson, et al.
EFSA Journal. European Food Safety Authority|November 18, 2024
Assessment of soy leghemoglobin produced from genetically modified <i>Komagataella phaffii</i>, under Regulation (EC) No 1829/2003 (application EFSA-GMO-NL-2019-162), Josep Casacuberta, Francisco Barro, et al.
JAMA Oncology|November 8, 2019
Communication With Older Patients With Cancer Using Geriatric Assessment: A Cluster-Randomized Clinical Trial From the National Cancer Institute Community Oncology Research ProgramSupriya G Mohile, Ronald M Epstein, Arti Hurria, et al.
EFSA Journal. European Food Safety Authority|August 6, 2025
New developments in biotechnology applied to animals: An assessment of the adequacy and sufficiency of current EFSA guidance for animal risk assessment, Josep Casacuberta, Francisco Barro, et al.
EFSA Journal. European Food Safety Authority|February 18, 2021
Evaluation of existing guidelines for their adequacy for the molecular characterisation and environmental risk assessment of genetically modified plants obtained through synthetic biology, Hanspeter Naegeli, Jean-Louis Bresson, et al.
International Journal of Cancer|September 24, 2022
Circulating immune markers and risks of non-Hodgkin lymphoma subtypes: A pooled analysisJongeun Rhee, Brenda M Birmann, Anneclaire J De Roos, et al.
EFSA Journal. European Food Safety Authority|August 31, 2023
Assessment of genetically modified oilseed rape MS11 for food and feed uses, import and processing, under Regulation (EC) No 1829/2003 (application EFSA-GMO-BE-2016-138), Hanspeter Naegeli, Jean-Louis Bresson, et al.
EFSA Journal. European Food Safety Authority|July 7, 2020
Assessment of genetically modified maize Bt11 × MIR162 × MIR604 × 1507 × 5307 × GA21 and subcombinations, for food and feed uses, under Regulation (EC) No 1829/2003 (application EFSA-GMO-DE-2011-103), Hanspeter Naegeli, Jean-Louis Bresson, et al.
EFSA Journal. European Food Safety Authority|July 8, 2025
Assessment of genetically modified soybean DBN9004 (application EFSA-GMO-BE-2019-165), Josep Casacuberta, Francisco Barro, et al.
Pageof 146